JAK2 and metabolic dysfunction-associated steatohepatitis: Through these models, we sought to comprehensively investigate the role and mechanistic implications of Lp-PLA2 in the context of NASH, with a particular focus on its interaction with the JAK2/STAT3 signaling pathway.